Indivior PLC (OTCMKTS:INVVY – Get Free Report) shares were down 1.8% on Thursday . The company traded as low as $21.64 and last traded at $21.85. Approximately 8,100 shares were traded during trading, an increase of 112% from the average daily volume of 3,825 shares. The stock had previously closed at $22.25.
Indivior Stock Performance
The firm has a market capitalization of $3.01 billion, a P/E ratio of 20.81 and a beta of 0.35. The business has a fifty day moving average of $21.85 and a 200-day moving average of $21.85.
Indivior Company Profile
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom.
Further Reading
- Five stocks we like better than Indivior
- The How And Why of Investing in Oil Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Buy Cheap Stocks Step by Step
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
